
SMR Young Investigator Award
SMR Young Investigator Award – Benjamin Izar, MD, PhD
Learn more about our upcoming Galas and Signature Events Learn More
Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...
SMR Young Investigator Award – Benjamin Izar, MD, PhD
Melanoma is a lethal form of skin cancer because it has a high propensity to metastasize, especially to the brain (often causing death). Compounding this problem is the obs...
Description: For patients with melanoma, timely diagnosis and prompt treatment are important for optimal outcomes, but some groups of patients may face barriers to accessin...
Description: Pigmentation, or the coloring of the skin, hair and mucous membranes, has been shown to influence melanoma risk. Most, if not all traits and diseases, have a g...
Description: Findings from this grant will shed light on 1) how stemness is sustained by modulating PI3Kδ signaling in T cells using FDA-approved drugs and 2) how transcri...
Description: While immunotherapy treatment has radically improved the outcomes of patients with advanced melanoma, around half of patients have no response. This is in part...
Description: According to the latest published statistics by the NIH, there are almost half a million individuals who are cancer survivors after having been diagnosed with ...
Description: While several medications, immune stimulating agents, and radiation therapies have been developed and used for the treatment of melanoma, the treatment options...
Medical Student Award – Nneoma Adaku
Description: Background: Racial inequities in melanoma survival have been documented in the literature. The largest Black-white difference in overall cancer survival is for...
Description: Immunotherapy has been shown to be effective in treating melanoma, even at an early stage of disease. Patients with Stage II melanoma are now able to receive a...
Description: Immune checkpoint inhibitor therapy has greatly improved survival of patients with late-stage melanoma. However, about 2/3 of patients do not benefit from this...
Oct 16, 2025 ET
Oct 30, 2025 ET